Judge Nixes Eli Lilly's Axiron Patents In Win For Generics
A federal judge on Monday largely shut down Eli Lilly & Co.'s patent suit aiming to block generic versions of its testosterone drug Axiron, ruling that three of the four accused...To view the full article, register now.
Already a subscriber? Click here to view full article